No Cover Image

Journal article 185 views

Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma

Jedd D. Wolchok, Vanna Chiarion-Sileni, Piotr Rutkowski, C. Lance Cowey, Dirk Schadendorf Orcid Logo, John Wagstaff, Paola Queirolo, Reinhard Dummer, Marcus O. Butler, Andrew G. Hill, Michael A. Postow Orcid Logo, Caroline Gaudy-Marqueste, Theresa Medina, Christopher D. Lao, John Walker, Iván Márquez-Rodas, John B.A.G. Haanen, Massimo Guidoboni, Michele Maio, Patrick Schöffski, Matteo S. Carlino, Shahneen Sandhu, Céleste Lebbé, Paolo A. Ascierto Orcid Logo, Georgina V. Long Orcid Logo, Corey Ritchings, Ayman Nassar, Margarita Askelson, Melanie Pe Benito, Wenjia Wang, F. Stephen Hodi, James Larkin

New England Journal of Medicine, Volume: 392, Issue: 1, Pages: 11 - 22

Swansea University Author: John Wagstaff

Full text not available from this repository: check for access using links below.

Check full text

DOI (Published version): 10.1056/nejmoa2407417

Published in: New England Journal of Medicine
ISSN: 0028-4793 1533-4406
Published: Massachusetts Medical Society 2025
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa69784
College: Faculty of Medicine, Health and Life Sciences
Issue: 1
Start Page: 11
End Page: 22